Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Current Taxes (2023 - 2025)

Historic Current Taxes for Vivos Therapeutics (VVOS) over the last 3 years, with Q3 2025 value amounting to $727000.0.

  • Vivos Therapeutics' Current Taxes changed N/A to $727000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $727000.0, marking a year-over-year change of. This contributed to the annual value of $481000.0 for FY2024, which is 4709.48% up from last year.
  • According to the latest figures from Q3 2025, Vivos Therapeutics' Current Taxes is $727000.0.
  • In the past 5 years, Vivos Therapeutics' Current Taxes registered a high of $727000.0 during Q3 2025, and its lowest value of $327000.0 during Q4 2023.
  • Its 3-year average for Current Taxes is $539800.0, with a median of $533000.0 in 2025.
  • Data for Vivos Therapeutics' Current Taxes shows a peak YoY increase of 4709.48% (in 2024) and a maximum YoY decrease of 4709.48% (in 2024) over the last 5 years.
  • Vivos Therapeutics' Current Taxes (Quarter) stood at $327000.0 in 2023, then soared by 47.09% to $481000.0 in 2024, then surged by 51.14% to $727000.0 in 2025.
  • Its Current Taxes stands at $727000.0 for Q3 2025, versus $631000.0 for Q2 2025 and $533000.0 for Q1 2025.